ALBIREO PHARMA, INC. Quarterly Other Assets, Noncurrent in USD from Q2 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Albireo Pharma, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q2 2011 to Q3 2022.
  • Albireo Pharma, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2022 was $13.8M, a 112% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $13.8M +$7.31M +112% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $14.6M +$8.5M +139% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $14.4M +$8.28M +135% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $15.2M +$9.19M +153% Dec 31, 2021 10-Q 2022-11-08
Q3 2021 $6.52M +$115K +1.8% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $6.12M -$44K -0.71% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $6.15M +$192K +3.22% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $6M +$591K +10.9% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $6.4M +$823K +14.8% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $6.16M +$5.05M +453% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $5.96M +$4.75M +393% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $5.41M +$5.04M +1367% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $5.58M +$5.18M +1309% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $1.12M +$693K +164% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.21M +$760K +169% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $369K -$406K -52.4% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $396K -$107K -21.3% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $422K -$107K -20.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $449K -$145K -24.4% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $775K +$257K +49.6% Dec 31, 2017 10-K 2019-03-06
Q3 2017 $503K Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $529K Jun 30, 2017 10-Q 2017-08-21
Q1 2017 $594K Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $518K Dec 31, 2016 10-K 2018-03-27
Q3 2011 $7K Sep 30, 2011 10-K 2012-12-21
Q2 2011 $9K Jun 30, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.